SANICHI
0133
HPI
03060
TALAMT
2259
MICROLN
0126
GPACKET
0082
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 559.87%2.11M | 170.51%1.28M | 104.19%53K | -129.76%-1.84M | -41.85%921.28K | -45.09%319K | -206.14%-1.81M | -154.85%-1.27M | -63.05%6.18M | -89.13%1.58M |
Net profit before non-cash adjustment | 70.66%-404K | -29.37%-163K | -5.31%-1.61M | -599.07%-13.47M | -352.63%-10.44M | -19.84%-1.38M | -255.56%-126K | -205.39%-1.53M | 73.33%-1.93M | 65.61%-2.31M |
Total adjustment of non-cash items | -64.75%1.6M | -9.97%1.37M | -15.04%1.36M | 54.63%11.87M | 82.61%4.21M | 147.73%4.53M | -32.04%1.53M | 23.43%1.6M | -43.58%7.67M | -74.33%2.31M |
-Depreciation and amortization | ---- | ---- | ---- | 1.41%6.59M | ---- | ---- | ---- | ---- | -7.38%6.5M | ---- |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 36,597.94%4.45M | ---- | ---- | ---- | ---- | -99.79%12.13K | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---39.44K | ---- |
-Share of associates | ---- | ---- | ---- | -40.38%40.75K | ---- | ---- | ---- | ---- | 75.17%68.36K | ---- |
-Disposal profit | ---- | ---- | ---- | -117.17%-13.3K | ---- | ---- | ---- | ---- | 236.68%77.47K | ---- |
-Other non-cash items | -64.75%1.6M | -9.97%1.37M | -15.04%1.36M | -24.44%797.24K | -59.01%-6.85M | 147.73%4.53M | -32.04%1.53M | 23.43%1.6M | 29.57%1.06M | -13.51%-4.31M |
Changes in working capital | 132.17%912K | 102.15%69K | 122.75%304K | -153.72%-234.07K | 351.47%7.15M | -2,763.64%-2.84M | -421.59%-3.21M | -208.55%-1.34M | -95.79%435.69K | -87.12%1.58M |
-Change in receivables | ---- | ---- | ---- | -766.58%-561.59K | ---- | ---- | ---- | ---- | -100.58%-64.81K | ---- |
-Change in inventory | ---- | ---- | ---- | -2,340.75%-881.8K | ---- | ---- | ---- | ---- | 89.61%-36.13K | ---- |
-Change in payables | ---- | ---- | ---- | 125.36%1.21M | ---- | ---- | ---- | ---- | 204.84%536.62K | ---- |
-Changes in other current assets | 132.17%912K | 102.15%69K | 122.75%304K | ---- | ---- | -2,763.64%-2.84M | -421.59%-3.21M | -208.55%-1.34M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | ||||||||||
Interest received (cash flow from operating activities) | ||||||||||
Tax refund paid | 107.74%24K | 38.48%-219K | 46.91%-206K | 35.78%-1.07M | 95.28%-15.39K | 72.15%-310K | -85.42%-356K | -1,041.18%-388K | -71.54%-1.67M | 25.49%-326.09K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | 23,555.56%2.13M | 148.85%1.06M | 90.75%-153K | -164.40%-2.91M | -28.00%905.89K | 101.69%9K | -243.05%-2.17M | -172.74%-1.65M | -71.34%4.52M | -91.10%1.26M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -141.15%-1.25M | -37.17%-2.68M | -165.05%-2.02M | -241.50%-5.96M | -207.91%-2.72M | -199.43%-520K | -193.24%-1.95M | -6.14%-761K | 55.36%-1.74M | 92.40%-884.28K |
Net intangibles purchase and sale | ---- | ---- | ---- | ---102.93K | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment product transactions | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- | --0 | ---- |
Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Interest received (cash flow from investment activities) | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Investing cash flow | 513.85%2.15M | -37.17%-2.68M | -165.05%-2.02M | -247.35%-6.06M | -219.44%-2.82M | -199.43%-520K | -193.24%-1.95M | -6.14%-761K | 55.36%-1.74M | 92.40%-884.28K |
Financing cash flow | ||||||||||
Net issuance payments of debt | 331.77%2.95M | 223.08%2.06M | -91.20%398K | 601.59%5.88M | 22,682.00%2.35M | 272.91%683K | -340.95%-1.68M | 404.92%4.52M | 27.11%-1.17M | 114.42%10.31K |
Increase or decrease of lease financing | ---231K | ---1.15M | -1,460.00%-78K | -11.64%-199.22K | -7,830.54%-194.22K | --0 | --0 | 87.50%-5K | 34.79%-178.45K | 93.66%-2.45K |
Cash dividends for minorities | ---- | ---- | ---- | 50.00%-1.05M | --0 | --0 | --0 | ---1.05M | -100.00%-2.1M | 0.00%-1.05M |
Interest paid (cash flow from financing activities) | -14.10%-259K | -316.67%-300K | 28.07%-123K | -13.66%-740.08K | 33.66%-270.08K | -224.29%-227K | 16.28%-72K | -94.32%-171K | 17.66%-651.14K | 37.25%-407.14K |
Financing cash flow | 439.25%2.46M | 135.05%613K | -94.02%197K | 194.79%3.89M | 230.05%1.88M | 175.87%456K | -297.50%-1.75M | 304.59%3.3M | -10.19%-4.1M | 19.88%-1.45M |
Net cash flow | ||||||||||
Beginning cash position | -2,255.88%-2.93M | -132.06%-1.93M | -99.08%47K | -20.58%5.13M | -98.69%81K | -98.00%136K | -6.14%6.01M | -20.57%5.13M | 485.37%6.46M | 7.64%6.2M |
Current changes in cash | 12,354.55%6.74M | 82.87%-1.01M | -323.95%-1.97M | -282.40%-5.08M | 96.83%-34.06K | 90.98%-55K | -1,528.71%-5.87M | 1,731.48%881K | -116.34%-1.33M | -255.18%-1.08M |
End cash Position | 4,601.23%3.81M | -2,255.88%-2.93M | -132.06%-1.93M | -99.09%46.51K | -99.09%46.51K | -98.69%81K | -98.00%136K | -6.14%6.01M | -20.58%5.13M | -20.58%5.13M |
Free cash flow | 236.01%695K | 60.73%-1.62M | 10.14%-2.17M | -735.14%-9.16M | -665.60%-2.11M | 59.83%-511K | -625.89%-4.12M | -255.11%-2.42M | -87.73%1.44M | -97.21%373.02K |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.